Global Cord Blood (Global Cord Blood) EV-to-EBITDA : -7.76 (As of Apr. 26, 2024)

Global Cord Blood EV-to-EBITDA Chart

Global Cord Blood Annual Data
	Trend	Mar13	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
EV-to-EBITDA		Get a 7-Day Free Trial					9.91	1.69	-4.52	-4.18	-5.61

Global Cord Blood Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
EV-to-EBITDA	Get a 7-Day Free Trial															-4.18	-3.70	-4.62	-5.34	-5.61

Competitive Comparison of Global Cord Blood's EV-to-EBITDA

For the Diagnostics & Research subindustry, Global Cord Blood's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Cord Blood's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Global Cord Blood's EV-to-EBITDA falls into.

Global Cord Blood EV-to-EBITDA Calculation

Global Cord Blood's EV-to-EBITDA for today is calculated as:

Global Cord Blood's current Enterprise Value is $-738.4 Mil.
Global Cord Blood's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $95.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood  (OTCPK:CORBF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Global Cord Blood's PE Ratio for today is calculated as:

Global Cord Blood's share price for today is $1.25.
Global Cord Blood's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.644.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Global Cord Blood EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Global Cord Blood's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Cord Blood (Global Cord Blood) Business Description